Trial Profile

Influence of Pramipexole Extended Release on Medication Adherence in Real Life Care of Parkinson's Disease.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pramipexole (Primary)
Indications Parkinson's disease
Focus Therapeutic Use
Sponsors Boehringer Ingelheim Pharmaceuticals

Most Recent Events

24 Apr 2012 Actual end date changed from Jul 2011 to Sep 2011 as reported by ClinicalTrials.gov.
24 Apr 2012 Actual patient number changed from 330 to 329 as reported by ClinicalTrials.gov.
19 Oct 2011 Actual number of patients reported by ClinicalTrials.gov (n=330).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com